In the latest quarter, 7 analysts provided ratings for Guardant Health (NASDAQ:GH), showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 6 | 1 | 0 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 1 | 0 | 0 | 0 | 0 |
2M Ago | 2 | 1 | 0 | 0 | 0 |
3M Ago | 2 | 0 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $34.29, a high estimate of $44.00, and a low estimate of $28.00. This current average represents a 6.69% decrease from the previous average price target of $36.75.
![bigjpg](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240718/0-4f4dde470b54361b39ccc6f837399d03-0-f66d7c1418d6d3a590a2671277c7647e.webp/bigjpg)
Analyzing Analyst Ratings: A Detailed Breakdown
A clear picture of Guardant Health's perception among financial experts is painted with a thorough...
ログインすると全部閲覧できます。
ログイン